Two of the world's leading medtech companies have been collaborating to improve patient access to CGM technology. It now looks like Medtronic and Abbott could be close to gaining FDA clearance and moving forward to the next phase of their partnership.

Singleton Associates, P.A., announced Wednesday it has inked a multiyear partnership with the Bloomfield, Connecticut, payer effective June 1. 

"As the nation’s largest payer of healthcare, Medicare’s policies on coverage and payment for AI technologies are especially critical," AdvaMed says. 

Two lots of Ropivacaine Hydrochloride Injection infusion bags from Amneal Pharmaceuticals are being removed from hospitals due to plastic fibers coming loose in the fluids.

The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic hardships and rigid resource limitations. According to the Heart Rhythm Society, one way to effectively combat this issue is the development of more AFib Centers of Excellence.

The ongoing trade war between the United States and China could jeopardize the availability of contrast agents used for medical imaging. 

Radiology practices are already operating on razor thin margins, with price increases prompting calls for congressional action to prevent further damage. 

"Using a similar approach of front-loaded, declining incentives, an AI-focused program could help accelerate adoption and implementation," write Richard Heller and Nina Kottler.